AGIOLAX

This brand name is authorized in Brazil, Spain, Finland, France, Hong Kong, Ireland, Israel, Netherlands, Poland

Active ingredients

The drug AGIOLAX contains one active pharmaceutical ingredient (API):

1 Sennosides UNII F887D1637W - SENNOSIDE B

The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses. Read about Sennosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AB56	Senna glycosides, combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB56
A06AC51	Ispaghula, combinations	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AC Bulk producers
Discover more medicines within A06AC51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541519120017117, 541519120017217
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 56285
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 182529, 395829
Country: FR	Base de données publique des médicaments	Identifier(s): 66768488
Country: HK	Department of Health Drug Office	Identifier(s): 57858
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2920
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100003283